Licensing, Selling and Finance in the Phar...

Dekorationsartikel gehören nicht zum Leistungsumfang.

Sprache: Englisch

46,70 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Lieferzeit 4-7 Werktage

Kategorien:

Der Artikel ist nicht in deutscher Sprache verfasst.
Die Sprache der Produktbeschreibung und Details kann in Englisch angegeben sein. Sollten Sie Verständnisprobleme haben, wenden Sie sich gerne an uns.

Beschreibung

Licensing, Selling and Finance in the Pharmaceutical and Healthcare Industries is an assessment of the turbulent state of pharmaceutical and biotechnology markets as we enter the second decade of the 21st century. At the same time, the book offers a cautionary evaluation of the future financing of innovation in terms of what's gone wrong and how to

Über den Autor

Martin Austin is Managing Director of TransformRx GmbH, formed in 2005 to provide business advice to clients on investment and business development. He is also a Partner in MarraM Advisors, specialising in Industrial Biotechnology, a Board member of RSA AG and Chairman of Zestagen SA a biotech start-up in Lausanne. He was previously a Principal in the Paul Capital Partners Royalty Funds, a USA-based specialist in Secondary Private Equity and Alternative Asset Investments and previously Head of Business Development for the Pharmaceuticals Division at F. Hoffmann-La Roche. After a broad ranging career in the Pharmaceutical industry, progressing through Sales and Marketing roles with GD Searle in the early 1980's, he went on to become Business Development Manager with Lorex Pharmaceuticals before leaving to become a founding Director of Machine Intelligence Technologies. He was then appointed Managing Director of MHIG Ltd, an international joint venture in Market Research, prior to joining Roche.

Inhaltsverzeichnis

Introduction; Part I The Challenge; Chapter 1 Novel Market Challenges; Chapter 2 What is Intellectual Property?; Part II Models and Solutions; Chapter 3 Market Opportunities; Chapter 4 Modeling and Forecasting; Chapter 5 Valuation; Chapter 6 Development Costs of Intellectual Property; Chapter 7 Commercial Strategy for Intellectual Property; Chapter 8 Marketing Intellectual Property in Healthcare; Chapter 9 Licensing, Selling and Finance; Chapter 10 Contract Execution; Chapter 11 Agreements;

Erscheinungsjahr:	2024
Fachbereich:	Management
Genre:	Importe , Wirtschaft
Rubrik:	Recht & Wirtschaft
Medium:	Taschenbuch
Inhalt:	Einband - flex.(Paperback)
ISBN-13:	9781032837376
ISBN-10:	1032837373
Sprache:	Englisch
Einband:	Kartoniert / Broschiert
Autor:	Austin, Martin
Hersteller:	Taylor & Francis Ltd
Verantwortliche Person für die EU:	Libri GmbH, Europaallee 1, D-36244 Bad Hersfeld, gpsr@libri.de
Maße:	223 x 245 x 19 mm
Von/Mit:	Martin Austin
Erscheinungsdatum:	24.06.2024
Gewicht:	0,354 kg

Ähnliche Produkte